SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
99%+ purity, US-manufactured, HPLC tested, COA included
It benefits nutrient absorption, metabolism, brain function, and more
From Imbalanced to Stable: What Normalization Actually Looks Like Normal hormones are a range, not a single perfect value
Do note, pernicious anemia rarely visits alone